Loading...
Amneal Pharmaceuticals Private Limited — Doxycycline Export Profile: Buyers & Destinations
Loading...
Indian Pharmaceutical Exporter · #5 for Doxycycline · $1.1M export value · DGFT Verified
Amneal Pharmaceuticals Private Limited is the #5 Indian exporter of Doxycycline with $1.1M in export value and 23 verified shipments. Amneal Pharmaceuticals Private Limited holds a 1.0% market share in Doxycycline exports across 1 countries. The company exports 28 pharmaceutical products worth $106.5M across 19 therapeutic categories.
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $28.9M | 579 | 60.9% |
| AUSTRALIA | $4.7M | 143 | 9.9% |
| ETHIOPIA | $2.4M | 47 | 4.9% |
| UNITED KINGDOM | $2.3M | 116 | 4.8% |
| BELGIUM | $1.8M | 263 | 3.8% |
| SOUTH AFRICA | $1.1M | 73 | 2.3% |
| NETHERLANDS | $1.1M | 172 | 2.3% |
| SRI LANKA | $1.1M | 54 | 2.3% |
| UNITED ARAB EMIRATES | $799.5K | 1,099 | 1.7% |
| VIETNAM | $700.0K | 14 | 1.5% |
India exports Doxycycline to 149 countries. The top destination is UNITED STATES (60.9%), followed by AUSTRALIA and ETHIOPIA.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| AVET PHARMACEUTICALS INC | UNITED STATES | $6.3M | 126 |
| EVERSANA LIFE SCIENCE SERVICES | UNITED STATES | $3.3M | 66 |
| J. KNIPPER & COMPANY | UNITED STATES | $3.0M | 60 |
| J. KNIPPER & COMPANY, | UNITED STATES | $1.8M | 35 |
| J KNIPPER COMPANY | UNITED STATES |
India exported $35.9M worth of Doxycycline through 5,999 shipments from 408 suppliers to 149 countries, serving 1,051 buyers globally. Amneal Pharmaceuticals Private Limited contributes $1.1M to this total, accounting for 1.0% of India's Doxycycline exports.
Amneal Pharmaceuticals Private Limited's average Doxycycline shipment value is $50.0K per consignment, based on 23 shipments totaling $1.1M.
Amneal Pharmaceuticals Private Limited ranks #5 among 408 Indian Doxycycline exporters with a 1.0% market share. The top 3 exporters are ALEMBIC PHARMACEUTICALS LIMITED ($7.0M), USV PRIVATE LIMITED ($6.3M), STRIDES PHARMA SCIENCE LIMITED ($4.5M). Amneal Pharmaceuticals Private Limited processed 23 shipments to 1 destination countries.
What Amneal Pharmaceuticals Private Limited must comply with to export Doxycycline to its top destination countries
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Approval Process
Exporters ranked immediately above and below #5 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 12 | S KANT HEALTHCARE LIMITED | $1.2M | 45 | 3 | $27.2K |
| 13 | MEDOPHARM | $1.2M | 48 | 21 | $25.2K |
| 5 | AMNEAL PHARMACEUTICALS PRIVATE LIMITED ★ | $1.1M | 23 | 1 | $50.0K |
| 9 | GLAND PHARMA LTD | $1.1M | 23 | 1 | $50.0K |
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 1,633 | 27.2% |
| SAHAR AIR | 1,215 | 20.3% |
| NHAVA SHEVA SEA (INNSA1) | 338 | 5.6% |
| DELHI AIR CARGO ACC (INDEL4) | 336 | 5.6% |
| Bombay Air | 315 | 5.3% |
| DELHI AIR | 219 | 3.7% |
| JNPT | 188 | 3.1% |
| JNPT/ NHAVA SHEVA SEA | 156 | 2.6% |
Amneal's export operations are navigating a complex geopolitical landscape. The ongoing Israel-Iran tensions have led to disruptions in Red Sea shipping routes, escalating shipping costs and transit times for Indian pharmaceutical exporters. This situation necessitates strategic adjustments in logistics and supply chain management to mitigate potential delays and increased expenses.
Conversely, the U.S.-China trade tensions have opened avenues for Indian pharmaceutical companies like Amneal to strengthen their presence in the U.S. market. With the U.S. seeking to diversify its supply chains, Indian exporters are well-positioned to fill the gap, provided they meet stringent regulatory standards.
In the European Union, compliance with the Falsified Medicines Directive (FMD) remains a critical requirement. Amneal's partnership with Orion Corporation to commercialize products in Europe underscores the importance of adhering to these regulations to ensure market access and maintain credibility.
Maintaining compliance with international regulatory standards is paramount for Amneal. In August 2025, the U.S. FDA issued a warning letter to Amneal Pharmaceuticals Private Limited's Gujarat facility, citing significant violations of Current Good Manufacturing Practice (CGMP) regulations, including inadequate investigations into particulate contamination in sterile injectables. (fda.gov) Addressing these compliance issues is crucial for sustaining export operations and upholding the company's reputation in global markets.
Amneal Pharmaceuticals Private Limited exports 28 products worth $106.5M. Beyond Doxycycline, top products include Iron, Spironolactone, Gabapentin, Potassium, Naproxen. View the complete Amneal Pharmaceuticals Private Limited profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Doxycycline — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Amneal Pharmaceuticals Private Limited's Doxycycline exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Amneal Pharmaceuticals Private Limited
Full Company Profile →
28 products · $106.5M total trade · 19 categories
| $1.6M |
| 31 |
| MYLAN INSTITUTIONAL INC 2898 | UNITED STATES | $1.0M | 20 |
| MYLAN INSTITUTIONAL INC | UNITED STATES | $900.0K | 18 |
| CARDINAL THIRD PARTY LOGISTICS | UNITED STATES | $800.0K | 16 |
| AMNEAL PHARMACEUTICALS, LLC (KY) | UNITED STATES | $700.0K | 14 |
| NORTHSTAR DISTRIBUTION CENTER 8912 | UNITED STATES | $700.0K | 14 |
India's Doxycycline is purchased by 1,051 buyers worldwide. The top buyer is AVET PHARMACEUTICALS INC (UNITED STATES), followed by EVERSANA LIFE SCIENCE SERVICES and J. KNIPPER & COMPANY.
Registration on Australian Register of Therapeutic Goods (ARTG). Bioequivalence and quality data per TGA guidelines.
Timeline: 10–14 months
GMP & Export Requirements
TGA GMP clearance; PIC/S-aligned inspection. PIC/S certificate from India may expedite.
TGA sponsor licence for Australian importer; GMP clearance per manufacturing site
Note: TGA participates in PIC/S mutual recognition.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
| 14 | MEPRO PHARMACEUTICALS PRIVATE LIMITED | $1.1M | 65 | 3 | $16.2K |
Amneal Pharmaceuticals Private Limited ranks #5 among 408 Indian Doxycycline exporters. Average shipment value of $50.0K compared to the market average of $87.9K. The closest competitors by value are S KANT HEALTHCARE LIMITED and MEDOPHARM.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 149+ countries, 1,051+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for Amneal Pharmaceuticals Private Limited.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Doxycycline. For current shipment-level data, contact TransData Nexus.